Avery Dennison Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Avery Dennison Corporation on February 20, 2024, with the earliest event reported on that date. The filing addresses corporate governance changes, specifically the departure of a long-serving director and the appointment of a new director, as well as amendments to the Company's bylaws.
Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Director Departure: Julia A. Stewart, a 21-year member of the Board of Directors, notified the Company on February 20, 2024, that she will not stand for reelection at the Annual Meeting of Stockholders on April 25, 2024, to focus on a health and wellness venture.
- Director Appointment: On February 22, 2024, the Board appointed Maria Fernanda Mejia as a director, effective immediately. She has been assigned to the Audit Committee.
- Compensation: Ms. Mejia received an equity award of 132 restricted stock units (RSUs) prorated for the remaining term, vesting in full on the first anniversary of the grant date.
- Bylaw Amendments: On February 22, 2024, the Board amended and restated the Company's bylaws. Key changes include clarifying stockholder notice obligations, updating advance notice provisions, specifying voting standards for contested elections, and allowing stockholders to amend bylaws via a majority of shares represented rather than votes cast.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business performance. No specific risks or contingencies related to operations or finances are disclosed in this report.
Key Facts for Investor Verification
- Verify the composition of the Board of Directors following the departure of Julia A. Stewart and the appointment of Maria Fernanda Mejia.
- Review the full text of the Amended and Restated Bylaws (Exhibit 3.1) to understand changes to voting standards and stockholder proposal procedures.
- Confirm the vesting schedule and terms of the 132 RSUs granted to the new director.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial metrics.